tiprankstipranks
USANA Health (USNA)
NYSE:USNA
US Market
USNA
USANA Health
RESEARCH TOOLSreports
Want to see USNA full AI Analyst Report?

USANA Health (USNA) Ratios

177 Followers

USANA Health Ratios

USNA's free cash flow for Q1 2026 was $0.76. For the 2026 fiscal year, USNA's free cash flow was decreased by $ and operating cash flow was $0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.51 2.24 2.00 3.52 2.65
Quick Ratio
 1.69 1.45 1.50 3.00 2.18
Cash Ratio
 1.39 1.23 1.30 2.78 2.01
Solvency Ratio
 0.33 0.32 0.40 0.62 0.56
Operating Cash Flow Ratio
 0.14 0.17 0.44 0.59 0.72
Short-Term Operating Cash Flow Coverage
 1.19 1.60 2.65 89.87 15.08
Net Current Asset Value
$ 150.05M$ 131.76M$ 117.33M$ 282.19M$ 219.15M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.05 0.02 0.02
Debt-to-Equity Ratio
 0.03 0.03 0.07 0.03 0.03
Debt-to-Capital Ratio
 0.03 0.03 0.07 0.03 0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.36 1.39 1.41 1.27 1.37
Debt Service Coverage Ratio
 3.22 3.50 2.77 80.58 12.84
Interest Coverage Ratio
 73.12 60.41 236.03 355.23 560.49
Debt to Market Cap
 0.04 0.04 0.03 <0.01 <0.01
Interest Debt Per Share
 0.80 0.80 2.07 0.70 0.73
Net Debt to EBITDA
 -1.90 -1.76 -1.44 -2.58 -2.11
Profitability Margins
Gross Profit Margin
76.72%78.29%79.43%79.44%79.24%
EBIT Margin
4.22%4.58%8.97%11.15%10.90%
EBITDA Margin
8.46%8.87%11.57%13.37%13.04%
Operating Profit Margin
5.30%5.50%7.76%10.11%10.78%
Pretax Profit Margin
4.35%4.49%8.94%11.12%10.88%
Net Profit Margin
0.96%1.16%4.92%6.93%6.94%
Continuous Operations Profit Margin
0.99%1.24%4.92%6.93%6.94%
Net Income Per EBT
22.04%25.91%55.05%62.26%63.85%
EBT Per EBIT
82.04%81.65%115.12%110.08%100.94%
Return on Assets (ROA)
1.20%1.45%5.62%10.08%11.63%
Return on Equity (ROE)
1.66%2.02%7.90%12.83%15.96%
Return on Capital Employed (ROCE)
7.89%8.28%10.90%18.11%23.77%
Return on Invested Capital (ROIC)
1.75%2.24%5.73%11.10%14.95%
Return on Tangible Assets
1.88%2.28%9.29%10.89%12.68%
Earnings Yield
2.57%2.98%6.18%6.18%6.77%
Efficiency Ratios
Receivables Turnover
 95.88 0.00 103.92 127.90 138.44
Payables Turnover
 13.28 11.63 14.67 18.81 18.76
Inventory Turnover
 2.24 1.96 2.52 3.08 3.09
Fixed Asset Turnover
 9.79 9.80 9.04 9.23 8.48
Asset Turnover
 1.25 1.25 1.14 1.46 1.67
Working Capital Turnover Ratio
 5.50 6.18 3.90 3.43 4.54
Cash Conversion Cycle
 139.47 155.09 123.45 101.88 101.32
Days of Sales Outstanding
 3.81 0.00 3.51 2.85 2.64
Days of Inventory Outstanding
 163.14 186.47 144.83 118.43 118.14
Days of Payables Outstanding
 27.48 31.37 24.89 19.41 19.46
Operating Cycle
 166.95 186.47 148.34 121.29 120.77
Cash Flow Ratios
Operating Cash Flow Per Share
 0.90 1.20 3.20 3.67 5.40
Free Cash Flow Per Share
 0.16 0.46 2.67 2.92 4.86
CapEx Per Share
 0.74 0.74 0.53 0.75 0.54
Free Cash Flow to Operating Cash Flow
 0.18 0.38 0.83 0.79 0.90
Dividend Paid and CapEx Coverage Ratio
 1.22 1.62 6.05 4.87 9.99
Capital Expenditure Coverage Ratio
 1.22 1.62 6.05 4.87 9.99
Operating Cash Flow Coverage Ratio
 1.19 1.60 1.56 5.35 7.54
Operating Cash Flow to Sales Ratio
 0.02 0.02 0.07 0.08 0.10
Free Cash Flow Yield
0.86%2.36%7.48%5.44%9.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 38.86 33.56 16.19 16.18 14.77
Price-to-Sales (P/S) Ratio
 0.37 0.39 0.80 1.12 1.03
Price-to-Book (P/B) Ratio
 0.63 0.68 1.28 2.08 2.36
Price-to-Free Cash Flow (P/FCF) Ratio
 116.85 42.35 13.36 18.38 10.95
Price-to-Operating Cash Flow Ratio
 20.74 16.16 11.16 14.61 9.86
Price-to-Earnings Growth (PEG) Ratio
 -0.52 -0.46 -0.48 -2.16 -0.39
Price-to-Fair Value
 0.63 0.68 1.28 2.08 2.36
Enterprise Value Multiple
 2.52 2.64 5.44 5.80 5.76
Enterprise Value
 197.25M 216.70M 537.83M 714.59M 749.68M
EV to EBITDA
 2.52 2.64 5.44 5.80 5.76
EV to Sales
 0.21 0.23 0.63 0.78 0.75
EV to Free Cash Flow
 66.61 25.42 10.56 12.73 8.02
EV to Operating Cash Flow
 11.86 9.70 8.82 10.12 7.22
Tangible Book Value Per Share
 17.81 16.97 15.23 23.39 19.98
Shareholders’ Equity Per Share
 29.54 28.70 27.91 25.83 22.57
Tax and Other Ratios
Effective Tax Rate
 0.77 0.72 0.45 0.38 0.36
Revenue Per Share
 50.33 49.81 44.82 47.84 51.86
Net Income Per Share
 0.48 0.58 2.20 3.31 3.60
Tax Burden
 0.22 0.26 0.55 0.62 0.64
Interest Burden
 1.03 0.98 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.01 0.01 0.01
SG&A to Revenue
 0.45 0.36 0.70 0.00 0.00
Stock-Based Compensation to Revenue
 0.01 0.01 0.02 0.02 0.01
Income Quality
 1.71 2.08 1.45 1.11 1.50
Currency in USD